Interacting Drugs |
Efavirenz, emtricitabine, and tenofovir vs Carvedilol |
Security Level |
 |
Mechanism |
Carvedilol: CYP2C9 Inhibitors (Moderate) may increase the serum concentration of Carvedilol. Specifically, concentrations of the S-carvedilol enantiomer may be increased. |
Management |
Monitor therapy |
Efavirenz, emtricitabine, and tenofovir vs Carvedilol
Post Review about Efavirenz, emtricitabine, and tenofovir vs Carvedilol Click here to cancel reply.
Other Interactions of Efavirenz, emtricitabine, and tenofovir
Other Interactions of Carvedilol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.